Plasma proteome in multiple sclerosis disease progression
Arjan Malekzadeh(University of Amsterdam), Charlotte E. Teunissen(Amsterdam Neuroscience), Cyra E Leurs(Vrije Universiteit Amsterdam), Martijn D. Steenwijk(Amsterdam Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Wessel N. van Wieringen(University Medical Center), Yvonne Naegelin(University Hospital of Basel), Michael A�mann(University Hospital of Basel), Jens Kühle(University of Basel)
Cited by 29
Related Papers
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809